20,892 results match your criteria Scarring Alopecia


Evaluation of Association of Vitamin D in Alopecia Areata: A Case-control Study of 100 Patients in a Tertiary Rural Hospital of Southern India.

Indian Dermatol Online J 2019 Jan-Feb;10(1):45-49

Department of Dermatology, Raja Rajeswari Medical College and Hospital, Kambipura, Mysore Road, Bangalore, Karnataka, India.

Background: Alopecia areata is a common autoimmune disorder which is characterized by non-scarring hair loss. Vitamin D plays an important role in immune regulation, cell growth, differentiation, and maintenance of hair cycle.

Aims And Objectives: (1) To evaluate serum vitamin D levels in alopecia areata. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/idoj.IDOJ_84_18DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6362755PMC
February 2019

Clinico-Epidemiological Profile of Patients with Vitiligo: A Retrospective Study from a Tertiary Care Center of North India.

Indian Dermatol Online J 2019 Jan-Feb;10(1):38-44

Department of Dermatology, Venereology and Leprosy, Dr. R. P. Govt. Medical College, Kangra (Tanda), Himachal Pradesh, India.

Background: We studied clinico-epidemiological features of 945 patients with vitiligo with an objective to delineate epidemiological and clinical aspects of vitiligo from this part of the country.

Materials And Methods: The medical records of patients with vitiligo attending outpatient clinic over a 5-year period from January 2013 to December 2017 were analyzed retrospectively for this descriptive, observational study.

Results: There were 449 men and 496 women (m:f 1:1. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/idoj.IDOJ_124_18DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6362747PMC
February 2019

Hyperadrenocorticism Caused by a Pituitary Ganglioglioma in a Dog.

Vet Pathol 2019 Feb 17:300985819829530. Epub 2019 Feb 17.

5 Laboratory of Veterinary Surgery, Department of Veterinary Clinical Medicine, Faculty of Veterinary Medicine, School of Veterinary Medicine, Nippon Veterinary and Life Science University, Musashino-shi, Tokyo, Japan.

An 11-year-old castrated male Chihuahua dog was presented with complaints of polyuria, polydipsia, abdominal enlargement, and alopecia. Hyperadrenocorticism was diagnosed on the basis of clinical signs, blood tests, adrenocorticotropin-stimulation test results, and an elevated serum adrenocorticotropin concentration. Contrast-enhanced magnetic resonance imaging showed that the pituitary gland was enlarged, compatible with a pituitary macroadenoma. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0300985819829530DOI Listing
February 2019

A Summary of 2018 and What Lies Ahead for Dermatology and Therapy in 2019.

Dermatol Ther (Heidelb) 2019 Feb 15. Epub 2019 Feb 15.

Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester NIHR BRC, University of Manchester, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13555-019-0283-4DOI Listing
February 2019

Citalopram-Associated Alopecia: A Case Report and Brief Literature Review.

Curr Drug Saf 2019 Feb 14. Epub 2019 Feb 14.

Department of Psychiatry, Western Michigan University, Homer Stryker M.D. School of Medicine, Kalamazoo, MI . United States.

Background: Selective Serotonin Reuptake Inhibitors (SSRIs) are the first-line treatments for various psychiatric disorders. SSRIs offer improved side effect profile compared to older treatments, which improve patient adherence and quality of life.

Case Report: Here we discuss a case of an uncommon, but distressing side effect of citalopram. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1574886314666190215115857DOI Listing
February 2019

Alopecia neoplastica as a sign of visceral malignancies: a systematic review.

J Eur Acad Dermatol Venereol 2019 Feb 14. Epub 2019 Feb 14.

Centro Oncologico ad Alta Tecnologia Diagnostica, Azienda Unità Sanitaria Locale - IRCCS di Reggio, Emilia, Italy.

Alopecia neoplastica (AN) from visceral tumors is a rare form of cutaneous metastasis in which internal malignancies spread to the scalp. The diagnosis of AN may be very challenging, especially when its onset precedes the diagnosis of the primary tumor. We aimed to improve the knowledge on AN, highlighting that in case of scarring localized alopecia, a differential diagnosis with metastasis should always be considered. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jdv.15498DOI Listing
February 2019

Estimating utilities/disutilities for high-risk metastatic hormone-sensitive prostate cancer (mHSPC) and treatment-related adverse events.

Qual Life Res 2019 Feb 14. Epub 2019 Feb 14.

Patient Centered Sciences, Mapi, Boston, USA.

Purpose: To capture UK societal health utility values for high-risk metastatic hormone-sensitive prostate cancer (mHSPC) and the disutility associated with treatment-related adverse events (AEs) to inform future cost-utility analyses.

Methods: A literature review, and patient and clinical expert interviews informed the development of health states characterising mHSPC symptoms and the impact of treatment-related AEs on health-related quality of life (HRQL). Three base health states were developed describing a typical patient with high-risk mHSPC: receiving androgen deprivation therapy (ADT) [Base State 1]; receiving docetaxel plus ADT [Base State 2]; completed docetaxel and still receiving ADT whose disease has not yet progressed [Base State 3]. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11136-019-02117-9DOI Listing
February 2019

Genetic Susceptibility to Alopecia.

Authors:
Jouni Uitto

N Engl J Med 2019 Feb 13. Epub 2019 Feb 13.

From the Department of Dermatology and Cutaneous Biology, Sidney Kimmel Medical College, Philadelphia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMe1900042DOI Listing
February 2019

Variant PADI3 in Central Centrifugal Cicatricial Alopecia.

N Engl J Med 2019 Feb 13. Epub 2019 Feb 13.

From the Department of Dermatology (L.M., O.S., A.P., M.P., E.W., L.S., V.B., J.M., E.S.) and the Institute of Pathology (A.G.), Tel Aviv Medical Center, the Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine (L.M., A.P., J.M., E.S.), and the Department of Cell and Developmental Biology (O.I., T.R., N.S.), Tel Aviv University, Tel Aviv, and the Schulich Faculty of Chemistry, Technion, Haifa (N.A.) - all in Israel; the Institute of Human Genetics, University of Bonn, School of Medicine and University Hospital Bonn, Bonn, Germany (M.-T.R., R.C.B.); L'Unité Différenciation Epitheliale et Autoimmunité Rhumatoïde (UDEAR), INSERM, Université Paul Sabatier, Université de Toulouse Midi-Pyrénées, Toulouse, France (M.-C.M., M.S.); the Department of Dermatology, Wake Forest Baptist Medical Center, Winston-Salem, NC (L.U., A.M.); and the Dermatology Department, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa (N.C.D).

Background: Central centrifugal cicatricial alopecia (CCCA) is the most common form of scarring alopecia among women of African ancestry. The disease is occasionally observed to affect women in families in a manner that suggests an autosomal dominant trait and usually manifests clinically after intense hair grooming. We sought to determine whether there exists a genetic basis of CCCA and, if so, what it is. Read More

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1816614
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1816614DOI Listing
February 2019
2 Reads

JAK inhibitors for alopecia areata: a systematic review and meta-analysis.

J Eur Acad Dermatol Venereol 2019 Feb 14. Epub 2019 Feb 14.

Department of Dermatology, Liverpool Hospital, Sydney, Australia.

Background: There have been a number of case reports and small clinical trials reporting promising outcomes of JAK inhibitors tofacitinib, ruxolitinib, and baracitinib for alopecia areata (AA). The majority of the literature to date is based on small volume data, with a lack of definitive evidence or guidelines.

Objective: To determine the expected response of AA to JAK inhibitor therapy, and factors which influence response and recurrence rates. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jdv.15489DOI Listing
February 2019

Ischemic modified albumin as a new biomarker in predicting oxidative stress in alopecia areata

Turk J Med Sci 2019 Feb 11;49(1):129-138. Epub 2019 Feb 11.

Background/aim: Results show that oxidative stress is a pathophysiologic factor for alopecia areata (AA); however, the markers used can be confounding. Thus, we aimed to investigate the role of oxidative stress in the pathogenesis of AA through an evaluation of ischemia-modified albumin (IMA); other markers of the oxidant/antioxidant system, such as SOD, CAT, GSH-ST, and MDA; and contributing clinical risk factors.

Materials And Methods: The usefulness of IMA as a new marker for oxidative stress was compared with that of other markers and evaluated in patients with AA. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3906/sag-1708-35DOI Listing
February 2019

Genetic analysis of a novel antioxidant multi-target iron chelator, M30 protecting against chemotherapy-induced alopecia in mice.

BMC Cancer 2019 Feb 13;19(1):149. Epub 2019 Feb 13.

Division of RI application, Korea Institute of Radiological and Medical Sciences, 75 Nowon-Gil, Gongneung-Dong, Nowon-Gu, Seoul, 01812, Korea.

Background: Chemotherapy-induced alopecia has been well documented as a cause of distress to patients undergoing cancer treatment. Almost all traditional chemotherapeutic agents cause severe alopecia. Despite advances in the treatment of chemotherapy-induced alopecia, there is no effective treatment for preventing chemotherapy-induced alopecia. Read More

View Article

Download full-text PDF

Source
https://bmccancer.biomedcentral.com/articles/10.1186/s12885-
Publisher Site
http://dx.doi.org/10.1186/s12885-019-5323-zDOI Listing
February 2019
2 Reads

En coup de sabre.

Cutis 2019 Jan;103(1):34-36

St. Joseph Mercy Hospital System, Reichert Health Center, Ypsilanti, Michigan, USA.

En coup de sabre (ECDS) is a rare form of localized scleroderma that typically manifests in children and women. It presents as a fibrous pansclerotic plaque extending in a bandlike distribution on the frontoparietal scalp with surrounding scarring alopecia. Many patients have comorbid central nervous system involvement in addition to the cutaneous findings. Read More

View Article

Download full-text PDF

Source
January 2019

Trichoscopy features of trichotillomania.

Pediatr Dermatol 2019 Feb 11. Epub 2019 Feb 11.

Department of Dermatology, Hospital Clinico Universitario, Valencia, Spain.

Trichotillomania is a form of traction alopecia resulting from repetitive and compulsive hair pulling and plucking. Trichotillomania and patchy alopecia areata may have similar clinical and dermoscopic features in some cases. On trichoscopic examination, the presence of black dots, coiled or hook hair, shafts of varying lengths with fraying or split ends (trichoptilosis), and an absence of exclamation mark hairs and yellow dots are suggestive of trichotillomania. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/pde.13756DOI Listing
February 2019

The Effectiveness of Oral Mini-Pulse Methylprednisolonein - the Treatment of Alopecia Areata in Vietnam.

Open Access Maced J Med Sci 2019 Jan 29;7(2):291-292. Epub 2019 Jan 29.

University of Rome G. Marconi, Rome, Italy.

Background: Systemic corticosteroid is used to treat alopecia areata, but it is associated with side effects. Mini-pulse therapy is thought to be effective but able to reduce side effects.

Aim: The study aimed to evaluate the effectiveness of oral mini-pulse methylprednisolone in the treatment of alopecia areata. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3889/oamjms.2019.097DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6364712PMC
January 2019

Efficacy and Safety of Methotrexate in Combination with Mini Pulse Doses of Methylprednisolone in Severe Alopecia Areata. The Vietnamese Experience.

Open Access Maced J Med Sci 2019 Jan 23;7(2):200-203. Epub 2019 Jan 23.

University of Rome G. Marconi, Rome, Italy.

Background: Treatment of severe alopecia areata remains very difficult, especially in alopecia areata totalis and alopecia areata universalis. Methotrexate is known to be effective in the treatment of severe and chronic autoimmune disorders.

Objective: To assess the effectiveness and safety of MTX in combination with mini pulse dose of methylprednisolone in the treatment of severe alopecia areata. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3889/oamjms.2019.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6364718PMC
January 2019

A Study of the Histopathological Features of Alopecias on Transverse Sections of Scalp Biopsies.

Indian J Dermatol 2019 Jan-Feb;64(1):47-54

Department of Pathology, All India Institute of Medical Sciences, New Delhi, India.

Background: Transverse sections of scalp biopsies are performed for the assessment of alopecias and are considered advantageous over vertical sections.

Aim: The aim was to study the histopathological features of alopecias on transverse sections of scalp biopsies.

Methods: It was a descriptive study. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/ijd.IJD_477_17DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340243PMC
February 2019
1 Read

The Association of Metabolic Syndrome and Insulin Resistance in Early-Onset Androgenetic Alopecia in Males: A Case-Control Study.

Indian J Dermatol 2019 Jan-Feb;64(1):23-27

Department of Dermatology, Venereology and Leprosy, Adichunchanagiri Institute of Medical Sciences, Mandya, Karnataka, India.

Background: Men with premature androgenetic alopecia (AGA) are found to be susceptible to cardiovascular diseases, metabolic syndrome (MS), diabetes mellitus and hypertension, and also premature baldness can have a definite negative impact on self-image and self-esteem in these patients. The aim of this study was to assess the strength of association between MS and/or insulin resistance (IR) in males with early-onset AGA.

Methods: A total of 50 male patients with premature AGA and equal number of age-matched controls were enrolled in the study. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/ijd.IJD_724_16DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340235PMC
February 2019
2 Reads

Clinical Profile of Androgenic Alopecia and Its Association with Cardiovascular Risk Factors.

Indian J Dermatol 2019 Jan-Feb;64(1):19-22

Department of Skin and VD, Amrita Institute of Medical Sciences, Kochi, Kerala, India.

Context: Androgenic alopecia (AGA) is a hereditary androgen-dependent disorder, characterized by gradual conversion of terminal hair into miniaturized hair and defined by various patterns. Common age group affected is between 30 and 50 years. Metabolic syndrome (MetS) is a cluster of cardiovascular risk factors that include diabetes and prediabetes, abdominal obesity, dyslipidemia, and hypertension. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/ijd.IJD_526_16DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340244PMC
February 2019
1 Read

Assessment of Metabolic Profile and Ischemia-modified Albumin Level in Patients with Alopecia Areata: A Case-Control Study.

Indian J Dermatol 2019 Jan-Feb;64(1):12-18

Department of Medical Biochemistry, Ankara Numune Training and Research Hospital, Ankara, Turkey.

Background: Alopecia areata (AA) is an autoimmune-mediated hair follicle disorder. In the literature, there is no study evaluating metabolic syndrome and levels of ischemia-modified albumin (IMA) which is proposed as an oxidative stress biomarker in patients with AA.

Aims: The aim was to investigate the presence of metabolic syndrome and the levels of IMA, small dense low-density lipoprotein (sd-LDL), and visfatin levels in AA patients. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/ijd.IJD_238_18DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340238PMC
February 2019
2 Reads

Alopecia Areata Different View; Heavy Metals.

Indian J Dermatol 2019 Jan-Feb;64(1):7-11

Department of Dermatology, Yuzuncu Yil University, Faculty of Medicine, Van, Turkey.

Background: Alopecia areata (AA) is a noncicatricial alopecia affecting any hair-bearing area. Although AA is considered to be an autoimmune disease, oxidative stress has been shown to be an important factor in the etiology of AA. Trace elements are highly essential for humans since they form the building blocks of large molecules, function as the cofactors of enzymes, and have some key biological functions. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/ijd.IJD_137_18DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340228PMC
February 2019
1 Read

Pathogenesis of Alopecia Areata Based on Bioinformatics Analysis.

Indian J Dermatol 2019 Jan-Feb;64(1):1-6

Department of Toxicology, School of Public Health, Shaanxi University of Chinese Medicine, Xi'an, China.

Background: Alopecia areata (AA) describes a sudden localized patchy alopecia. The cause of AA is not completely clear and its incidence may be related to genetic, autoimmune, and environmental factors.

Aim: To explore the possible mechanisms of AA and to provide a basis for the early diagnosis and treatment of AA. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/ijd.IJD_68_18DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340232PMC
February 2019

Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): a first-in-human, multicentre, phase 1-2 trial.

Lancet Oncol 2019 Feb 7. Epub 2019 Feb 7.

Department of Oncology, Phase 1 Unit, Rigshospitalet, Copenhagen, Denmark.

Background: Tisotumab vedotin is a first-in-human antibody-drug conjugate directed against tissue factor, which is expressed across multiple solid tumour types and is associated with poor clinical outcomes. We aimed to establish the safety, tolerability, pharmacokinetic profile, and antitumour activity of tisotumab vedotin in a mixed population of patients with locally advanced or metastatic (or both) solid tumours known to express tissue factor.

Methods: InnovaTV 201 is a phase 1-2, open-label, dose-escalation and dose-expansion study done at 21 centres in the USA and Europe. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(18)30859-3DOI Listing
February 2019
2 Reads

Safety of eribulin as third-line chemotherapy in HER2-negative, advanced breast cancer pre-treated with taxanes and anthracycline: OnSITE study.

Breast J 2019 Feb 8. Epub 2019 Feb 8.

Medical Oncology Department, Hospital 12 De Octubre, Madrid, Spain.

Eribulin is active and safe in heavily pre-treated metastatic breast cancer patients. Few safety data have been published in third line. We aimed to report the specific safety profile on third line beyond taxanes and anthracyclines in advanced breast cancer (ABC). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/tbj.13199DOI Listing
February 2019
1 Read

LICHENOID FOLLICULITIS OF THE SCALP IN FOUR PATIENTS WITH ICHTHYOSIFORM SKIN DISORDERS AND CICATRICIAL ALOPECIA.

J Cutan Pathol 2019 Feb 7. Epub 2019 Feb 7.

Department of Dermatology, Federal Fluminense University, Antonio Pedro University Hospital, Marques de Parana Avenue, Niteroi, 24220-900, Brazil.

Ichthyosis is a heterogeneous group of inherited skin disorders characterized by a defect of keratinization. Patients diagnosed with lamellar ichthyosis (LI) and some ichthyosiform syndromes, such as the Conradi-Hünermann-Happle syndrome (CHHS), usually present with hair loss. Even though only few dermatologic complaints carry as many emotional overtones as hair loss, there is extremely little data available in the literature regarding scalp histopathologic features on ichthyosis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cup.13439DOI Listing
February 2019

Polysaccharides as potential anticancer agents-A review of their progress.

Carbohydr Polym 2019 Apr 29;210:412-428. Epub 2019 Jan 29.

SVKM's Dr. Bhanuben Nanavati College of Pharmacy, Mumbai, India.

Cancer is one of the most common diseases seen in developed countries, with over 1.6 million new cases estimated in 2017, in the US alone. The current chemotherapeutic drugs available for the therapeutic management of cancer are associated with major adverse effects like alopecia, anemia, immunodeficiency, fatigue, peripheral neuropathy, fertility issues and neurological problems, to name a few of them. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carbpol.2019.01.064DOI Listing
April 2019
1 Read

Prostaglandins in androgenetic alopecia in 12 men and 4 female.

J Eur Acad Dermatol Venereol 2019 Feb 7. Epub 2019 Feb 7.

Universidad Autónoma de Nuevo León, Facultad de Medicina, Departamento de Dermatología, Monterrey, Mexico.

Androgenetic alopecia (AGA) is the most common form of hair loss in humans. Evidence suggests the participation of prostaglandins in the development of AGA. The aim of this study was to analyze the expression of the PTGDR2 (GPR44 receptor), PTGDS (Prostaglandin D2 synthase), and PTGES (Prostaglandin E synthase) transcripts in biopsies from balding scalp of hispanic patients with AGA and female androgenetic alopecia (FAGA). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jdv.15479DOI Listing
February 2019

[Androgen-secreting tumours of the ovaries].

Ugeskr Laeger 2019 Feb;181(6)

The diagnosis of an androgen-secreting tumour of the ovaries should be considered in women with hyperandrogenism. Clinical manifestations of hyperandrogenism include virilisation with hirsutism, vocal change, increased muscle mass, hypertrophy of clitoris and alopecia. Definitive diagnosis is made by histopathologic examination, and the most common diagnoses are granulosa cell tumour, ovarian stromal hyperplasia and Sertoli-Leydig cell tumour. Read More

View Article

Download full-text PDF

Source
February 2019
1 Read

Autoimmune-Associated Hemophagocytosis and Myelofibrosis in a Newly Diagnosed Lupus Patient: Case Report and Literature Review.

Case Rep Hematol 2019 9;2019:3879148. Epub 2019 Jan 9.

Section of Hematology, Department of Medicine, UP-Philippine General Hospital, Manila, Philippines.

Bone marrow abnormalities in SLE are now becoming increasingly recognized, suggesting that the bone marrow may also be an important site of target organ damage. In this study, we present a rare case of concurrent autoimmune hemophagocytic syndrome and autoimmune myelofibrosis, potentially life-threatening conditions, in a newly diagnosed SLE patient. We report a case of a 30-year-old Filipino woman who presented with a one-year history of fever, constitutional symptoms, exertional dyspnea, joint pains, and alopecia and physical examination findings of fever, facial flushing, cervical lymphadenopathies, and knee joint effusions. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2019/3879148DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343163PMC
January 2019
1 Read

Agreement Between Self-reported and Dermatologists' Diagnosis for Alopecia Areata and Atopic Dermatitis: A Bi-centric Prospective Study.

Acta Derm Venereol 2019 Feb 6. Epub 2019 Feb 6.

Department of Dermatology, University Hospital, FR-25000 Besançon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2340/00015555-3135DOI Listing
February 2019

Varied responses to and efficacies of hydroxychloroquine treatment according to cutaneous lupus erythematosus subtypes in Japanese patients.

J Dermatol 2019 Feb 5. Epub 2019 Feb 5.

Department of Environmental Immuno-Dermatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

Hydroxychloroquine is recommended as the first-line systemic treatment for cutaneous lupus erythematosus (CLE) in Western countries, and it was approved in Japan in 2016. However, the efficacy of hydroxychloroquine in various cutaneous lupus erythematosus subtypes in Japanese patients has not been elucidated to date. Therefore, we investigated the efficacy of hydroxychloroquine for the treatment of cutaneous manifestations according to CLE subtypes in Japanese patients. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/1346-8138.14802DOI Listing
February 2019
1 Read

Alopecia universalis. Partial response to tofacitinib.

Med Clin (Barc) 2019 Feb 1. Epub 2019 Feb 1.

Unidad de Gestión Clínica de Dermatología, Hospital Universitario San Cecilio, Granada, España.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.medcli.2018.11.006DOI Listing
February 2019
1 Read

Adverse Hair Reactions to New Targeted Therapies for Cancer.

Actas Dermosifiliogr 2019 Feb 1. Epub 2019 Feb 1.

Servicio de Dermatología, Hospital Universitario Ramón y Cajal, Madrid, España.

The advent of immune targeted therapies for cancer has radically changed the treatment and prognosis of many cancers. These drugs are called targeted therapies because they target specific pathophysiological mechanisms of cancer. This paradigm shift in cancer treatment, however, has resulted in new adverse dermatologic effects involving both the skin and its appendages. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00017310183057
Publisher Site
http://dx.doi.org/10.1016/j.ad.2018.10.019DOI Listing
February 2019
1 Read

First Italian case of frontal fibrosing alopecia in a male.

G Ital Dermatol Venereol 2019 Feb 4. Epub 2019 Feb 4.

Division of Dermatology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.23736/S0392-0488.19.06286-2DOI Listing
February 2019

Follicular mucinosis in patients with hematologic malignancies other than mycosis fungoides: A clinicopathologic study.

J Am Acad Dermatol 2019 Feb 1. Epub 2019 Feb 1.

Department of Pathology, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA.

Background: Follicular mucinosis (FM), defined by mucin accumulation within follicular epithelium, may occur in mycosis fungoides (MF). FM without MF is occasionally reported in systemic hematologic malignancies, and may be diagnostically challenging.

Objective: To describe clinicopathological characteristics of FM in patients with hematologic malignancies other than MF. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2019.01.062DOI Listing
February 2019
1 Read

Alopecic patches of the scalp: a variant of primary cutaneous follicle center B-cell lymphoma reported in a series of 14 cases.

J Eur Acad Dermatol Venereol 2019 Feb 4. Epub 2019 Feb 4.

INSERM, UMR976, Centre de Recherche sur la Peau.

Primary cutaneous follicle center lymphoma (PCFCL) is the most frequent primary cutaneous B-cell lymphoma. It presents usually with erythematous papules, plaques and tumors that predominate on the head, neck and upper trunk. The evolution is indolent but relapses are frequent. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jdv.15477DOI Listing
February 2019
1 Read

Serum biotin and zinc in male androgenetic alopecia.

J Cosmet Dermatol 2019 Feb 3. Epub 2019 Feb 3.

Department of Clinical Pathology, Faculty of Medicine, Benha University, Benha, Egypt.

Background: Male androgenetic alopecia (MAGA) is caused by the conversion of the terminal to vellus hair. Zinc is one of the most studied trace elements in hair disorders and biotin is one of the most prescribed supplement for its treatment.

Objectives: The study aimed to evaluate serum zinc and biotin levels in MAGA patients to answer the question if there is a value to add zinc or biotin as a supplements in the MAGA treatment. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jocd.12865DOI Listing
February 2019
1 Read

Pattern of skin diseases in a university hospital in Jeddah, Saudi Arabia: age and sex distribution.

Ann Saudi Med 2019 Jan-Feb;39(1):22-28

Dr. Hussein M. Alshamrani, Faculty of Medicine, King Abdulaziz University Hospital,, Jeddah 21333, Saudi Arabia, T: +966530204524, ORCID: http://orcid. org/0000-0001-9893-7528.

Background: Previous studies have investigated the pattern of dermatological diseases in some regions of Saudi Arabia, but studies on the prevalence of skin diseases in Jeddah are lacking.

Objectives: Assess the pattern of skin diseases in Jeddah based on age and sex differences and compare the results with those of previous studies conducted in other regions of Saudi Arabia and the Middle East.

Design: A cross-sectional prevalence study, retrospective. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5144/0256-4947.2019.22DOI Listing
February 2019
1 Read

Direct immunofluorescence findings in cicatricial alopecia: A retrospective study of 155 cases.

Indian J Pathol Microbiol 2019 Jan-Mar;62(1):103-106

Department of Dermatology, Maulana Azad Medical College, New Delhi, India.

Objectives: To study the direct immunofluorescence (DIF) in cicatricial alopecia (CA) patients.

Materials And Methods: Approximately, 155 skin biopsies from CA patients examined over 7 years (2009-2015). Special stains and Hematoxylin and Eosin were performed, and final histopathological diagnosis was made. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/IJPM.IJPM_428_18DOI Listing
February 2019
2 Reads

Lanostane-type triterpenes from the sclerotium of Inonotus obliquus (Chaga mushrooms) as proproliferative agents on human follicle dermal papilla cells.

J Nat Med 2019 Jan 31. Epub 2019 Jan 31.

Graduate School of Pharmaceutical Sciences, Tokushima University, Tokushima, 770-8505, Japan.

Chaga mushrooms, the sclerotium of Inonotus obliquus, have been used in Mongolia as a traditional hair shampoo to maintain healthy hair. Bioassay-guided fractionations of the extract of Chaga mushrooms using a proliferation assay on human follicle dermal papilla cells (HFDPCs) gave five lanostane-type triterpenes (1-5), whose structures were identified by spectroscopic evidence. Among these, lanosterol (1), inotodiol (3), lanost-8,24-diene-3β,21-diol (4), and trametenolic acid (5) demonstrated proproliferative effects on HFDPCs more potent than minoxidil, an anti-alopecia agent, used as the positive control. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11418-019-01280-0DOI Listing
January 2019

Comparative effectiveness of low-level laser therapy for adult androgenic alopecia: a system review and meta-analysis of randomized controlled trials.

Lasers Med Sci 2019 Jan 31. Epub 2019 Jan 31.

Department of Dermatology, Taipei Medical University Shuang Ho Hospital, No.291, Zhongzheng Rd., Zhonghe District, New Taipei City, 23561, Taiwan.

The purpose of this review is to explore the effectiveness of low-level laser therapy (LLLT) in the treatment of adult androgenic alopecia (AGA). A systematic search of studies on LLLT for AGA was conducted mainly in Pubmed, Embase, and Cochrane Systematic Reviews. The standardized mean difference (SMD) in the changes of hair density treated by LLLT versus sham devices was analyzed. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10103-019-02723-6DOI Listing
January 2019
1 Read

Intensity Modulated Radiation Therapy Versus Volumetric Arc Radiation Therapy in the Treatment of Glioblastoma-Does Clinical Benefit Follow Dosimetric Advantage?

Adv Radiat Oncol 2019 Jan-Mar;4(1):50-56. Epub 2018 Sep 28.

Department of Radiation Oncology, The University of Texas, MD Anderson Cancer Center, Houston, Texas.

Purpose: Volumetric modulated arc therapy (VMAT) has been shown by multiple planning studies to hold dosimetric advantages over intensity modulated radiation therapy (IMRT) in the management of brain tumors, including glioblastoma (GBM). Although promising, the clinical impact of these findings has not been fully elucidated.

Methods And Materials: We retrospectively reviewed consecutive patients with a pathologic-confirmed diagnosis of GBM who were treated between 2014 and 2015, a period that encompassed the transition from IMRT to VMAT at a single institution. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.adro.2018.09.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349632PMC
September 2018
1 Read

Managing thymic enlargement in Graves' disease.

Endocrinol Diabetes Metab Case Rep 2019 Jan 31;2019. Epub 2019 Jan 31.

Centre for Endocrine and Diabetes Sciences, University Hospital of Wales, Cardiff, UK.

Thymic enlargement (TE) in Graves' disease (GD) is often diagnosed incidentally when chest imaging is done for unrelated reasons. This is becoming more common as the frequency of chest imaging increases. There are currently no clear guidelines for managing TE in GD. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/EDM-18-0119DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365683PMC
January 2019
4 Reads

ORAL-FACIAL-DIGITAL SYNDROME TYPE I (CLINICAL CASE).

Georgian Med News 2018 Dec(285):47-51

Uzhhorod National University; Uzhgorod City Children's Clinical Hospital, Ukraine.

The oral-facial-digital syndrome belongs to a group of hereditary diseases, manifested by multiple birth defects (usually, the face and fingers). At the current stage, there are 14 genetic variations of the oral-facial-digital syndrome. The presence of various abnormalities of the oral cavity, face and fingers is common for all of them, but each syndrome has a specific phenotype or type of inheritance. Read More

View Article

Download full-text PDF

Source
December 2018
1 Read

Symptomatic Leishmaniasis in an Italian Segugio Dog from Northeastern Romania: A Case Report.

Iran J Parasitol 2018 Oct-Dec;13(4):673-678

Dept. of Public Health and Molecular Biology Laboratory, Faculty of Veterinary Medicine, University of Agricultural Sciences and Veterinary Medicine Ion Ionescu de la Brad, Iasi, Romania.

Leishmaniasis is a zoonotic parasitosis caused by a diphasic protozoan of the genus . The dogs are considered the main domestic reservoir of and its transmission occurs mainly through sand flies. We report the case of a 10 yr old Italian Segugio dog in Mar 2016 from Iasi County-Moldova Region, northeastern Romania, referred to a private clinic with progressive weight loss, dermal lesions over the muzzle, foot pads and over the right and left tarsal joints. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348206PMC
January 2019
1 Read

JAK inhibitors and alopecia areata.

Lancet 2019 01;393(10169):318-319

Department of Dermatology & Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USA; Centre for Dermatology Research, University of Manchester and NIHR Manchester Biomedical Research Centre, Manchester, UK.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01406736183298
Publisher Site
http://dx.doi.org/10.1016/S0140-6736(18)32987-8DOI Listing
January 2019
2 Reads